Intrinsic Value of S&P & Nasdaq Contact Us

COMPASS Pathways plc CMPS NASDAQ

NASDAQ Global Select • Healthcare • Medical - Care Facilities • GB • USD

SharesGrow Score
42/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$18.00
+202%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

COMPASS Pathways plc (CMPS) has a negative trailing P/E of -1.8, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 9.3 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -55.14%, forward earnings yield 10.74%. PEG 0.03 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (100/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.03); analyst target implies upside (+202%).
  • Forward P/E 9.3 — analysts expect a return to profitability with estimated EPS of $0.64 for FY2029.
  • PEG Ratio 0.03 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -55.14% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 10.74% as earnings recover.
  • Analyst consensus target $18.00 (+202% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 40/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
42/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
MOAT
34/100
→ Income
GROWTH
15/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — CMPS

Valuation Multiples
P/E (TTM)-1.8
Forward P/E9.3
PEG Ratio0.03
Forward PEG0.03
P/B Ratio-9.88
P/S Ratio0.00
EV/EBITDA-1.8
Per Share Data
EPS (TTM)$-3.07
Forward EPS (Est.)$0.64
Book Value / Share$-0.56
Revenue / Share$0.00
FCF / Share$-1.68
Yields & Fair Value
Earnings Yield-55.14%
Forward Earnings Yield10.74%
Dividend Yield0.00%
Analyst Target$18.00 (+202%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2018 -12.3 0.00 -11.34 0.00 -
2019 -32.1 0.52 73.96 0.00 -
2020 -28.2 -0.32 8.71 0.00 -
2021 -12.3 -1.88 3.11 0.00 -
2022 -3.7 -0.18 1.88 0.00 -
2023 -3.8 -0.51 1.98 0.00 -
2024 -1.6 1.91 1.65 0.00 -
2025 -2.2 -0.07 -12.21 0.00 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2018 $0.00 $0.00 $-13.22M -
2019 $-0.90 $0.00 $-19.61M -
2020 $-1.68 $0.00 $-60.33M -
2021 $-1.79 $0.00 $-71.74M -
2022 $-2.16 $0.00 $-91.51M -
2023 $-2.32 $0.00 $-118.46M -
2024 $-2.30 $0.00 $-155.12M -
2025 $-3.08 $0.00 $-287.86M -

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-1.54 $-2.56 – $-1.20 $560K $95.83K – $1.24M 5
2027 $-1.34 $-2.28 – $-0.85 $41.1M $7.03M – $90.95M 3
2028 $-0.85 $-2.18 – $0.07 $220.96M $37.81M – $488.96M 1
2029 $0.64 $-0.05 – $1.65 $542.08M $92.77M – $1.2B 1
2030 $2.48 $-0.19 – $6.38 $963.65M $164.91M – $2.13B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message